We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Treating Pancreatic Cancer With Arthritis Drug
News

Treating Pancreatic Cancer With Arthritis Drug

Treating Pancreatic Cancer With Arthritis Drug
News

Treating Pancreatic Cancer With Arthritis Drug

Mitochondrial Dynamics in Pancreatic Cancer. Credit: David Kashatus. Source: National Cancer Institute \ Univ. of Virginia Cancer Center
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Treating Pancreatic Cancer With Arthritis Drug"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Inside of our body cells are tiny little organs ("organelles") called mitochondria that serve as miniature power plants. They provide the energy necessary for metabolism to occur and our bodies to function.

Mitochondria are not static structures. They can bend and move and even divide or fuse with other mitochondria. Collectively known as "mitochondrial dynamics," mitochondrial fission and fusion play a role in a cell's response to stress. As might be expected, mitochondrial dynamics can go awry inside cancer cells.

The most common type of pancreatic cancer is PDAC, pancreatic ductal adenocarcinoma, which is a tumor that forms in the ducts (tubes) that deliver pancreatic juices (that aid in digestion) to the small intestine. The mitochondria of PDAC cells are unusually fragmented, indicating that processes promoting mitochondrial fission (division) outpace those that promote fusion.

Now, scientists believe that this imbalance in mitochondrial dynamics could serve as a target in the treatment of pancreatic cancer. Using a mouse model, researchers describe in the journal JCI Insights that an FDA-approved drug for the treatment of arthritis also happens to promote mitochondrial fusion in pancreatic cancer cells and, crucially, extends survival time.

How an Arthritis Drug Could Help Treat Pancreatic Cancer

How does the drug, called leflunomide, work? Based on their investigation, the authors showed that it increased the expression of a protein that is involved in mitochondrial fusion. A beautiful micrograph (see figure) shows the striking changes that occur inside cancer cells exposed to the drug. The left side of the figure depicts a control with fragmented mitochondria; the right side depicts a long, fused, tubular mitochondrion in response to leflunomide treatment.

The cancer cells don't seem to be very happy with this. The authors then demonstrated that the fused mitochondria are systematically destroyed in a process called mitophagy. From the cancer cell's perspective, this is counterproductive because it is destroying its own power supply. As a result, in various mouse models of pancreatic cancer, leflunomide prolonged survival.

All the usual caveats applicable to animal studies apply to this research, as well. What's interesting, however, is that this paper serves as a sort of proof-of-principle demonstrating that dysfunctional mitochondrial dynamics could be a viable target in cancer therapy. And because leflunomide is already FDA-approved, it should be relatively easy to get it into clinical trials for pancreatic cancer.

Reference: Meifang Yu, et al. (2019) Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight.  DOI: 10.1172/jci.insight.126915

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement